Lexby WheresMyMEPGet Pro free

Novartis International AG has 77 disclosed EU lobbying meetings from 2024-10-03 to 2026-06-10: 18 with the European Commission and 59 with Members of the European Parliament. Source: EU Transparency Register no. 91269481588-28, Commission disclosures and MEP declarations. Methodology

Novartis International AG

EU lobbying footprint — who they meet, and on what.

Register no.
91269481588-28 ↗
Disclosed meetings
77 (18 Commission · 59 MEP)
Period
2024-10-03 → 2026-06-10

Declared fields of interest: Borders and security · Business and industry · Competition · Consumers · Customs · Digital economy and society · Economy, finance and the euro · Employment and social affairs · Environment · External relations · Institutional affairs · International co-operation and development

Lobbying profile

as declared 2026-03-10
Category
Companies & groups
Legal status
Corporation
Declared lobbying cost
€2,500,000
Lobbying FTEs
3.25
Members
5
LobbyFacts / Transparency Register source ↗

At a glance

Most-met policy areas
  • Health6
  • Technology2
Commission officials
  • Olivér Várhelyi3
  • Laszlo Kristoffy1
  • Carmen Laplaza Santos1
  • Jana Dabbelt1
  • Vincenzo Matano1

Disclosed meetings

Newest first, showing the most recent 60 of 77. EC = European Commission, EP = Member of the European Parliament.

Lobbying in these areas

Who lobbies on Healthcare & Medical Devices →Who lobbies on Technology & Digital →

Frequently asked

How many EU lobbying meetings has Novartis International AG disclosed?

Novartis International AG (EU Transparency Register no. 91269481588-28) appears in 77 disclosed meetings with EU officials and MEPs between 2024-10-03 and 2026-06-10: 18 with the European Commission and 59 with Members of the European Parliament.

What does Novartis International AG lobby on?

Novartis International AG's disclosed EU meetings most often concern Health, Technology. Every meeting and its topic is listed with its official source on this page.

Who does Novartis International AG meet in Brussels?

Across its disclosed meetings, Novartis International AG has met Commission officials including Olivér Várhelyi, Laszlo Kristoffy, Carmen Laplaza Santos, and MEPs including FERENC Viktória, NEVADO DEL CAMPO Elena, HADJIPANTELA Michalis. These are counts of officially disclosed meetings, not a measure of influence.

Primary sources

Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.

Get the EU lobbying brief

We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.

See how this affects your company →Ask Lex about Novartis International AG →